SEC Form 4 Reporting Owner · CIK 0001632384
Joseph C Galante
Director at Cumberland Pharmaceuticals Inc · Director at Pinnacle Financial Partners Inc
Bought (12 mo)
—
Sold (12 mo)
—
Form 4 Filings
24
Companies
2
Filing Activity
2026-03-20
first filed 2021-02-10
Trading record
Open-market buys
+$127K
13 filings
Open-market sales
−$296K
1 filing
Sales under a 10b5-1 plan
—
Not disclosed on 1 sale filing
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| CPIXCumberland Pharmaceuticals Insider trading | Director | 18 | 21,022 | — | +21,022 | 63,656 2026-03-20 |
| PNFPPinnacle Financial Partners Insider trading | Director | 6 | 1,000 | 4,000 | −3,000 | 28,168 2024-03-04 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.